ZMB Research Program Oncology

ZMB Research Program
Oncology

Oncology

The concept of this research programme is to understand fundamental processes in tumor biology in order to develop novel molecularly defined and rationally applied cancer treatments. Participating researchers from biology, experimental and clinical medicine study tumors as "biological systems" and so called "neo-organs". A large variety of approaches, experimental systems and methodologies are in place to analyse many aspects of tumor development, growth, progression and tumor cell migration.

A first focus lies on the investigation of the behaviour of malignant cells, their signalling interactions, cell death (apoptosis) and proliferation rates, as well as changes in their differentiation program. Moreover, as most drug targets are proteins, researchers in this program focus on the molecular analysis of cancer-relevant proteins. Protein function is linked to expression levels, specific subcellular localization, interaction with other proteins and post-translational modifications. These events contribute to the various functional properties that are important for the malignant transformation of cells.

A second focus lies on the investigation of the molecular details of migration and metastasis of tumor cells, as well as cellular responses to cell damage. In addition, in cooperation with researchers from the Program on Immunology and Infectious Diseases, the interactions between the immune system and tumours are of particular interest.

Participating ZMB Members

Prof. Dr.Sebastian Bauer

Group: Translational Sarcoma Research

More

Prof. Dr. Dr.Jürgen Becker

Group: Translational Skin Cancer Research

More

Prof. Dr. Dr.Sven Brandau

Group:Otorhinolaryngology

More

Prof. Dr.Nicole Dünker

Group: Neuroanatomy

More

Dr.Farnoush Farahpour

Group: Bioinformatics and Computational Biophysics

More

Prof. Dr.Dagmar Führer-Sakel

Director of: Clinic for Endocrinology, Diabetology and Metabolism

More

Prof. Dr.Barbara M. Grüner

Group: Cell Plasticity and Metastasis

More

Prof. Dr.Barbara Grünwald

Group: Tumor Heterogeneity and Translational Systems Biology

More

Prof. Dr.Erich Gulbins

Director of: Department of Molecular Biology

More

Prof. Dr.Ken Herrmann

Group: Clinic for Nuclear Medicine

More

Prof. Dr.George Iliakis

Group: Radiation Biology

More

Prof. Dr.Jadwiga Jablonska-Koch

Group:Otorhinolaryngology (ENT)

More

Prof. Dr.Verena Jendrossek

Group: Molecular Cell Biology

More

Prof. Dr.Diana Klein

Group: Chemical Biology

More

Prof. Dr.Ralf Küppers

Director of: Institute of Cell Biology (Tumor Research)

More

Prof. Dr.Katharina Lückerath

Group: Preclinical Theranostics in Nuclear Medicine

More

PD Dr.Johann Matschke

Group: Metabolism and Radiation Response

More

Prof. Dr.Annette Paschen

Group: Molecular Tumor Immunology

More

Dr.Samuel Peña-Llopis

Group: Translational Genomics

More

Prof. Dr.Tienush Rassaf

Director of: Clinic for Cardiology and Vascular Medicine

More

Prof. Dr.Christian Reinhardt

Director of: Clinic for Hematology and Stem Cell Transplantation

More

Prof. Dr.Alexander Roesch

Group: Tumor Heterogeneity & Plasticity

More

Prof. Dr.Dirk Schadendorf

Director of: Clinic for Dermatology

More

Prof. Dr.Björn Scheffler

Group: Translational Neurooncology

More

Prof. Dr.Alexander Schramm

Group: Molecular Oncology

More

Prof. Dr.Martin Schuler

Director of: Department of Medical Oncology

More

Prof. Dr. Dr.Jens Siveke

Group: Bridge Institute for Experimental Tumor Therapy

More

Prof. Dr. Dr.Alpaslan Tasdogan

Group: Tumor Metabolism

More

PD Dr.Basant Kumar Thakur

Group: Cancer Exosome Research Lab

More

Dr.Silvia Vega-Rubín-de-Celis

Junior Research Group: Autophagy in Cancer

More